Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Spastic paraplegia: New light shed on cause

  • Sleep twitches light up the brain

  • Single-neuron 'hub' orchestrates activity of an entire brain circuit

  • 'Frenemy' in Parkinson's disease takes to crowdsourcing

  • Self-compassion key to positive body image, coping

  • Brief depression questionnaires could lead to unnecessary antidepressant prescriptions

  • CHICA system improves developmental delay screening, surveillance

  • The dangers of teens using marijuana

  • Jersey drivers admit to risky behaviors, poll finds

  • Talk therapy -- not medication -- best for social anxiety disorder, large study finds

  •